discover/
brain health
brain health
Accelerating our understanding of neurological disease and pioneering new therapeutic strategies to benefit human health.
One in three people are affected by neurological conditions. We’re finding new ways to treat them at the cellular level.
We need to dramatically speed up our understanding of how the human brain works, both in health and disease, so we can accelerate progress toward new treatments.
Thanks to major breakthroughs in how we study the brain at the cellular and circuit level, powerful advances in AI, and our global network of collaborators, we finally have the tools – and the scale – to deeply understand the human brain and target cells affected by disease.
The Brain Health accelerator will focus initially on Alzheimer’s, Parkinson’s, Huntington’s, ALS and Lewy body dementia. Our large-scale, highly collaborative, open science approach aims to develop more treatment options for patients faster.
Brain Health is launching with a commitment to-date of $400M. This includes $200M from the Allen Institute, whose primary supporter is the Fund for Science and Technology; $100M from the Bezos family; and an additional $100M from AWS, NIH, and EverythingALS.
brain health news
The human brain is unlike anything else in biology. By working in human tissue at a scale that's never been attempted before, we're finally able to see disease at the cellular level and change everything about how we treat it.
Ed Lein
Executive Vice President and Director, Brain Health
We have new tools and technology to understand and treat brain disease. Massive advances in AI, and groundbreaking tools to develop targeted therapies are opening up a whole new chapter of human neuroscience and medicine.
Ed Lein
Executive Vice President and Director, Brain Health
featured publications
open access brain atlases, tools, and data and knowledge resources
brain health events
brain health leadership
brain health team
.jpeg)
